335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences
CFO THOUGHT LEADER - A podcast by The Future of Finance is Listening
Categories:
A brief summary of this episode
CFO THOUGHT LEADER - A podcast by The Future of Finance is Listening
A brief summary of this episode